comparemela.com
  1. Home
  2. Live Updates
  3. Ruxolitinib Jakafi - Breaking News

Latest Breaking News On - Ruxolitinib jakafi - Page 1 : comparemela.com

Study Confirms: No Great Options for Treating VEXAS

Study Confirms: No Great Options for Treating VEXAS
medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.

France generalRuxolitinib jakafiJohn geverJerome hadjadjSaint antoine hospitalManaging editorRheum dis

Dr Kishtagari on the Impact of Momelotinib on the Management of Anemic Myelofibrosis

Ashwin Kishtagari, MD, discusses how momelotinib addresses unmet needs in the management of anemic myelofibrosis following disease progression on ruxolitinib.

Ashwin kishtagariRuxolitinib jakafiVanderbilt university medical center

Dr Gangat on the Evolution of JAK Inhibitors in Myelofibrosis

Naseema Gangat, MBBS, on evolution of JAK inhibitors for the treatment of patients with myelofibrosis.

Ruxolitinib jakafiNaseema gangatDepartment of medicineDivision of hematologyMayo clinic rochesterJak inhibitors

Concomitant Azoles Does Not Affect Clinical Outcomes With Ruxolitinib in Acute GVHD

Concomitant azoles did not negatively affect efficacy with ruxolitinib or best available therapy in patients with acute graft-versus-host disease.

San antonioUnited statesZahra mahmoudjafairUniversity of kansas medical centerTrial groupCellular therapyKansas medical centerConcomitant azolesRuxolitinib treatmentAcute graft versus host diseasePost hoc analysisRandomized phaseCellular therapy meetingsTransfus cell2024 transplantation amp cellular therapy meetingsPhase 3 reach2 study nct02913261

Hobbs Highlights Key Research in Hematologic Malignancies at the 2023 ASH Annual Meeting

Gabriela Hobbs, MD, discusses the significance of key research across myeloproliferative neoplasms from the 2023 ASH Annual Meeting.

Gabriela hobbsRuxolitinib jakafiNews networkMyeloproliferative neoplasms

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.